ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 282,22
-1,51%
Dow Jones
42 732,13
0,80%
DAX
19 906,08
-0,49%
Brent Oil
76,495
0,00%
Bitcoin
98 009,81
-0,20%
Registration Strip Icon for monitor Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Sunshine Biopharma Inc (SBFMW)

  7. Sunshine Biopharma Inc (SBFMW) Actualités

SBFMW

Sunshine Biopharma (SBFMW)

Sunshine Biopharma Inc
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:SBFMW
DateHeureSourceTitreSymboleSociété
10/12/202422h26Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:SBFMWSunshine Biopharma Inc
14/11/202422h28Edgar (US Regulatory)Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]NASDAQ:SBFMWSunshine Biopharma Inc
12/11/202417h29Edgar (US Regulatory)Form 424B4 - Prospectus [Rule 424(b)(4)]NASDAQ:SBFMWSunshine Biopharma Inc
12/11/202406h15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:SBFMWSunshine Biopharma Inc
06/11/202419h43Edgar (US Regulatory)Form POS AM - Post-Effective amendments for registration statementNASDAQ:SBFMWSunshine Biopharma Inc
05/11/202422h05Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:SBFMWSunshine Biopharma Inc
17/10/202422h05Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:SBFMWSunshine Biopharma Inc
15/05/202416h40Edgar (US Regulatory)Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSBNASDAQ:SBFMWSunshine Biopharma Inc
04/12/202314h30GlobeNewswire Inc.Sunshine Biopharma Moves Principal Office to New York CityNASDAQ:SBFMWSunshine Biopharma Inc
11/08/202314h30GlobeNewswire Inc.Sunshine Biopharma Reports 2023 Second Quarter Results: Revenues Up 3,600%NASDAQ:SBFMWSunshine Biopharma Inc
16/05/202315h58GlobeNewswire Inc.Sunshine Biopharma Announces Closing of $5.0 Million Private Placement Priced At-the-MarketNASDAQ:SBFMWSunshine Biopharma Inc
12/05/202314h00GlobeNewswire Inc.Sunshine Biopharma Announces Pricing of $5.0 Million Private Placement Priced At-the-MarketNASDAQ:SBFMWSunshine Biopharma Inc
11/05/202315h00GlobeNewswire Inc.Sunshine Biopharma Reports 2023 First Quarter Results: Revenues Up 2,100%NASDAQ:SBFMWSunshine Biopharma Inc
05/04/202314h00GlobeNewswire Inc.Sunshine Biopharma Reports Full Year Ended December 31, 2022 Financial Results and Provides Corporate UpdateNASDAQ:SBFMWSunshine Biopharma Inc
28/02/202313h30GlobeNewswire Inc.Sunshine Biopharma Signs Exclusive Worldwide License With University of Arizona For PLpro-Based Covid-19 TreatmentNASDAQ:SBFMWSunshine Biopharma Inc
10/02/202313h35GlobeNewswire Inc.Sunshine Biopharma Signs Research Agreement With the Jewish General Hospital to Advance the Development of Adva-27a Anticancer CompoundNASDAQ:SBFMWSunshine Biopharma Inc
19/01/202313h30GlobeNewswire Inc.Sunshine Biopharma Announces Share Repurchase ProgramNASDAQ:SBFMWSunshine Biopharma Inc
20/12/202214h00GlobeNewswire Inc.Sunshine Biopharma’s Annual Letter to ShareholdersNASDAQ:SBFMWSunshine Biopharma Inc
16/11/202214h00GlobeNewswire Inc.Sunshine Biopharma Enters Into a Collaboration Agreement with a Leading Lipid Nanoparticle Formulation Company for Its K1.1 Anticancer mRNA ProjectNASDAQ:SBFMWSunshine Biopharma Inc
20/10/202214h00GlobeNewswire Inc.Sunshine Biopharma Announces the Acquisition of Nora Pharma, Adding $10.7 Million in RevenueNASDAQ:SBFMWSunshine Biopharma Inc
04/08/202214h00GlobeNewswire Inc.Sunshine Biopharma Files Its Second Quarter Report With the SECNASDAQ:SBFMWSunshine Biopharma Inc
28/07/202214h10GlobeNewswire Inc.Sunshine Biopharma Increases Support for Anti-Coronavirus Collaborative Research With the University of ArizonaNASDAQ:SBFMWSunshine Biopharma Inc
28/04/202222h50GlobeNewswire Inc.Sunshine Biopharma, Inc. Announces Closing of $19.5 Million Private Placement Priced At-the-MarketNASDAQ:SBFMWSunshine Biopharma Inc
26/04/202206h41GlobeNewswire Inc.Sunshine Biopharma, Inc. Announces Pricing of $19.5 Million Private Placement Priced At-the-MarketNASDAQ:SBFMWSunshine Biopharma Inc
25/04/202214h00GlobeNewswire Inc.Sunshine Biopharma Files Patent Application Covering Recently Announced mRNA Molecules Found To Be Effective At Destroying Multidrug Resistant Cancer CellsNASDAQ:SBFMWSunshine Biopharma Inc
05/04/202214h00GlobeNewswire Inc.Sunshine Biopharma’s Newly Designed mRNA Molecules Prove Effective Against Multidrug Resistant Cancer CellsNASDAQ:SBFMWSunshine Biopharma Inc
14/03/202223h12GlobeNewswire Inc.Sunshine Biopharma, Inc. Announces Closing of $8.0 Million Private Placement Priced At-the-MarketNASDAQ:SBFMWSunshine Biopharma Inc
10/03/202215h17GlobeNewswire Inc.Sunshine Biopharma, Inc. Announces Pricing of $8.0 Million Private Placement Priced At-the-MarketNASDAQ:SBFMWSunshine Biopharma Inc
25/02/202216h20InvestorsHub NewsWireSUNSHINE BIOPHARMA EXPANDS ANTI-CORONAVIRUS DRUG DEVELOPMENT PROGRAM BY SIGNING A COLLABORATION AGREEMENT WITH THE UNIVERSITY OF ARIZONANASDAQ:SBFMWSunshine Biopharma Inc
25/02/202214h00GlobeNewswire Inc.Sunshine Biopharma Expands Anti-Coronavirus Drug Development Program By Signing A Collaboration Agreement With The University Of ArizonaNASDAQ:SBFMWSunshine Biopharma Inc
 Showing the most relevant articles for your search:NASDAQ:SBFMW

Dernières Valeurs Consultées

EU
RNO
Renault
EU
SGO
Cie de SaintGobain
FTSE
UKX
FTSE 100
NYSE
KO
Coca Cola
NYSE
MCD
McDonalds
USI
USTECH100
US Tech 100
EU
AI
Air Liquide
COIN
XRPUSD
Ripple
NASDAQ
MSFT
Microsoft
EU
MC
Lvmh Moet Hennessy Louis...
COIN
ETHUSD
Ethereum
EU
LR
Legrand
NASDAQ
AAPL
Apple
EU
BN
Danone
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2025 ADVFN PLC - Tous droits réservés